These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5453729)

  • 1. [Breast neoplasms, endocrine treatment and chemotherapy].
    Nissen-Meyer R
    Nord Med; 1970 Aug; 84(32):1019-20. PubMed ID: 5453729
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cooper's combination chemotherapy of metastasizing breast carcinoms].
    van Kaick G; Drings P; Fritsch H; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1371-3. PubMed ID: 4790187
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 5. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.
    Mortimer J; Livingston RB; Hardesty IJ; Groppe CW; Purvis JD; Gupta M; Flournoy N
    Cancer Treat Rep; 1984; 68(7-8):1017-8. PubMed ID: 6744334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer today.
    Kiang DT; Kennedy BJ
    Minn Med; 1984 Jun; 67(6):333-5, 344. PubMed ID: 6547995
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 10. Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
    Meakin JW; Allt WE; Beale FA; Bush RS; Clark RM; Fitzpatrick PJ; Hawkins NV; Jenkin RD; Pringle JF; Reid JG; Rider WD; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1980; Suppl 1():179-81. PubMed ID: 7032930
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical adjuvant trials in the United States.
    Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
    Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of advanced cancer of the breast with 5-fluorouracil.
    Vansant JH; Payne RL; Wheeler JR
    Am Surg; 1971 May; 37(5):287-9. PubMed ID: 5576598
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of, and indications for adjuvant chemotherapy in breast cancer].
    Brunner KW; Goldhirsch A; Joss R; Sonntag RW; Tschopp L
    Schweiz Med Wochenschr; 1981 Jun; 111(23):838-45. PubMed ID: 7268339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
    Zhang F; Yang Y; Smith T; Kau SW; McConathy JM; Esteva FJ; Kuerer HM; Symmans WF; Buzdar AU; Hortobagyi GN; Pusztai L
    Cancer; 2003 Apr; 97(7):1758-65. PubMed ID: 12655533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Our experience with cyclophosphamide, methotrexate and 5-fluorouracil in the postoperative treatment of breast carcinoma].
    Cavallaro V; Grasso F; Minutolo V; Turco F; Narbone G; Consoli A
    Chir Ital; 1982 Apr; 34(2):292-306. PubMed ID: 6896473
    [No Abstract]   [Full Text] [Related]  

  • 20. Ovarian function and adjuvant chemotherapy for breast cancer.
    Stoll BA
    Lancet; 1978 May; 1(8074):1159. PubMed ID: 77451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.